Login

u/Tom_2772

r/OTLK_Investors
With approximately $66M in cash and expected gross proceeds, OTLK has the capital to move LYTENAVA toward its U.S. commercial launch. FDA approved, funding secured, now it’s time to execute and deliver. 💎 Focus on August 14.
▲ 29 r/OTLK_Investors

With approximately $66M in cash and expected gross proceeds, OTLK has the capital to move LYTENAVA toward its U.S. commercial launch. FDA approved, funding secured, now it’s time to execute and deliver. 💎 Focus on August 14.

u/Tom_2772 — 7 days ago
▲ 10 r/OTLK_Investors

Big Pharma M&A set for mega year as patent expiries drive deal urgency

Just a thought experiment… This is an older Reuters article from May 1, 2026, but an interesting one. Reuters reported that Big Pharma was becoming more risk-on with M&A, particularly in deals under $10B, as upcoming patent expiries create urgency. With an $8.5B U.S. market alone, before even considering the UK and EU, and 12 years of exclusivity, I think there’s definitely something worth thinking about here. Nobody knows what Big Pharma or competitors might be planning. Just food for thought.

https://www.reuters.com/legal/transactional/big-pharma-ma-set-mega-year-patent-expiries-drive-deal-urgency-2026-05-01/

reddit.com
u/Tom_2772 — 8 days ago